One aim of the soon-to-be-published proposals is to make the health environment in the UK more innovation-friendly, in particular for medtech and digital health products. The final report on the government’s Accelerated Access Review should be out by the end of the month.
The keenly awaited report on the UK government-commissioned review that will propose the establishment of a managed accelerated pathway for a limited number of the most promising medical technologies and pharmaceuticals will be out soon. A publication date has yet to be set but hopefully it will be “in the next few weeks,” the Department of Health told Medtech Insight.
The final report on the Accelerated Access Review project was expected to be published in April after completion of the...
The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.
EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.
The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.
